A major new study for families with ADHD has been published in the Journal of Clinical Psychiatry. This article examines the complex comorbidities and the unique challenges presented by our patients in clinical practice. This study enrolled not only adults with ADHD but also those experiencing concurrent anxiety, depression, insomnia, and/or cannabis use. The findings demonstrate real-world improvements in mood, anxiety, and sleep when ADHD is better managed.
Read more: https://www.psychiatrist.com/jcp/viloxazine-extended-release-adhd-depression-anxiety-open-label-phase-4-trial/